Previous studies have explored the correlation between serum levels of pro-inflammatory (IL-2, IFN-γ, TNF-α) or anti-inflammatory cytokines (IL-4 and IL-10) with clinical or negative outcomes in individuals with COVID-19 [[13], [14], [15]]. The gene discussed is IL4; the disease is COVID-19.